Bottom line
What does RSPH hold?
RSPH held 63 positions as of Jul 31, 2026. Its largest holding is Bio-Techne Corp. at 2.13% of the fund, and the top 10 positions add up to 19.4%. By asset type it is 100% stocks, 2% cash & short-term funds.
Updated Sep 28, 2026
RSPH top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Bio-Techne Corp. | Stocks | 2.13% | $16.3M |
| 2 | IQVIA Holdings Inc. | Stocks | 2.00% | $15.3M |
| 3 | Baxter International Inc. | Stocks | 1.99% | $15.3M |
| 4 | Regeneron Pharmaceuticals, Inc. | Stocks | 1.96% | $15.1M |
| 5 | Mettler-Toledo International Inc. | Stocks | 1.94% | $14.9M |
| 6 | Charles River Laboratories International, Inc. | Stocks | 1.93% | $14.8M |
| 7 | Veeva Systems Inc. Veeva Systems Inc., Class A |
Stocks | 1.93% | $14.8M |
| 8 | DaVita Inc. | Stocks | 1.87% | $14.4M |
| 9 | Moderna, Inc. | Stocks | 1.85% | $14.1M |
| 10 | Thermo Fisher Scientific Inc. | Stocks | 1.84% | $14.1M |
| 11 | Abbott Laboratories | Stocks | 1.83% | $14.1M |
| 12 | Bristol-Myers Squibb Co. | Stocks | 1.82% | $13.9M |
| 13 | Universal Health Services, Inc. Universal Health Services, Inc., Class B |
Stocks | 1.80% | $13.8M |
| 14 | Labcorp Holdings Inc. | Stocks | 1.78% | $13.7M |
| 15 | Quest Diagnostics Inc. | Stocks | 1.77% | $13.6M |
| 16 | Amgen Inc. | Stocks | 1.77% | $13.5M |
| 17 | Incyte Corp. | Stocks | 1.76% | $13.5M |
| 18 | Becton, Dickinson and Co. | Stocks | 1.73% | $13.3M |
| 19 | DexCom, Inc. | Stocks | 1.73% | $13.2M |
| 20 | AbbVie Inc. | Stocks | 1.73% | $13.2M |
| 21 | Viatris Inc. | Stocks | 1.72% | $13.2M |
| 22 | Revvity, Inc. | Stocks | 1.72% | $13.2M |
| 23 | Cencora, Inc. | Stocks | 1.71% | $13.1M |
| 24 | Steris PLC | Stocks | 1.70% | $13.0M |
| 25 | Insulet Corp. | Stocks | 1.70% | $13.0M |
Source: SEC Form N-PORT, period ended Jul 31, 2026, filed Sep 28, 2026